HIMS stock crashes 25% on Friday after this key FDA update
Friday, 21 February 2025 ()
Shares of Hims & Hers Health plunged a massive 25% on Friday to hit an intraday low of around $49.01. The massive crash came after the US Food and Drug Administration (FDA) announced the end of the shortage of Novo Nordiskβs weight-loss drugs. Despite this setback, HIMS stock had surged 43% in the past five [β¦]
|
||||
|
|
||||
You Might Like |
||||
